ERIN FORSYTHE: Open Payments
NPI 1386083996 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $131 |
| Madrigal Pharmaceuticals | 1 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: REZDIFFRA, XIFAXAN.
Industry payments across WA — which companies pay providers there.
